Cargando…

Serglycin: At the Crossroad of Inflammation and Malignancy

Serglycin has been initially characterized as an intracellular proteoglycan expressed by hematopoietic cells. All inflammatory cells highly synthesize serglycin and store it in granules, where it interacts with numerous inflammatory mediators, such as proteases, chemokines, cytokines, and growth fac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Korpetinou, Angeliki, Skandalis, Spyros S., Labropoulou, Vassiliki T., Smirlaki, Gianna, Noulas, Argyrios, Karamanos, Nikos K., Theocharis, Achilleas D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888995/ https://www.ncbi.nlm.nih.gov/pubmed/24455486 http://dx.doi.org/10.3389/fonc.2013.00327

Ejemplares similares

Increased Expression of Serglycin in Specific Carcinomas and Aggressive Cancer Cell Lines
por: Korpetinou, Angeliki, et al.
Publicado: (2015)

Serglycin Is Implicated in the Promotion of Aggressive Phenotype of Breast Cancer Cells
por: Korpetinou, Angeliki, et al.
Publicado: (2013)

Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomas
por: Skandalis, Spyros S, et al.
Publicado: (2011)

Expression of Syndecan-4 and Correlation with Metastatic Potential in Testicular Germ Cell Tumours
por: Labropoulou, Vassiliki T., et al.
Publicado: (2013)

Serglycin activates pro-tumorigenic signaling and controls glioblastoma cell stemness, differentiation and invasive potential
por: Manou, Dimitra, et al.
Publicado: (2020)

Serglycin Is Involved in TGF-β Induced Epithelial-Mesenchymal Transition and Is Highly Expressed by Immune Cells in Breast Cancer Tissue
por: Tellez-Gabriel, Marta, et al.
Publicado: (2022)

IGF-IR cooperates with ERα to inhibit breast cancer cell aggressiveness by regulating the expression and localisation of ECM molecules
por: Afratis, Nikolaos A., et al.
Publicado: (2017)

Syndecans as Modulators and Potential Pharmacological Targets in Cancer Progression
por: Barbouri, Despoina, et al.
Publicado: (2014)

Extracellular Matrix Degradation and Tissue Remodeling in Periprosthetic Loosening and Osteolysis: Focus on Matrix Metalloproteinases, Their Endogenous Tissue Inhibitors, and the Proteasome
por: Syggelos, Spyros A., et al.
Publicado: (2013)

Serglycin in human cancers
por: Li, Xin-Jian, et al.
Publicado: (2011)

Complexity of matrix phenotypes
por: Iozzo, Renato V., et al.
Publicado: (2020)

Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression
por: Roy, Ananya, et al.
Publicado: (2017)

Serglycin in Quiescent and Proliferating Primary Endothelial Cells
por: Reine, Trine M., et al.
Publicado: (2015)

Clonal Hematopoiesis at the Crossroads of Inflammatory Bowel Diseases and Hematological Malignancies: A Biological Link?
por: Cumbo, Cosimo, et al.
Publicado: (2022)

Salicylate suppresses the oncogenic hyaluronan network in metastatic breast cancer cells
por: Karalis, Theodoros T., et al.
Publicado: (2020)

Serglycin is part of the secretory repertoire of LPS-activated monocytes
por: Kolseth, Ingrid Benedicte M, et al.
Publicado: (2015)

Targeting Serglycin Prevents Metastasis in Murine Mammary Carcinoma
por: Roy, Ananya, et al.
Publicado: (2016)

Cathepsin L promotes chemresistance to neuroblastoma by modulating serglycin
por: Du, Xiaohuan, et al.
Publicado: (2022)

Editorial: Molecules of the extracellular matrix as cancer targets
por: Karamanos, Nikos K., et al.
Publicado: (2022)

Serglycin proteoglycans limit enteropathy in Trichinella spiralis-infected mice
por: Roy, Ananya, et al.
Publicado: (2016)

Molecular Interactions Stabilizing the Promatrix Metalloprotease-9·Serglycin Heteromer
por: Dawadi, Rangita, et al.
Publicado: (2020)

The relationship between plasma serglycin levels and the diagnosis of diabetic retinopathy
por: Wang, Layi, et al.
Publicado: (2020)

Cdc13 at a crossroads of telomerase action
por: Churikov, Dmitri, et al.
Publicado: (2013)

At the Crossroads of Inflammation and Tumorigenesis
por: Cordon-Cardo, Carlos, et al.
Publicado: (1999)

UXT at the crossroads of cell death, immunity and neurodegenerative diseases
por: Han, Pengzhe, et al.
Publicado: (2023)

Significance of serglycin and its binding partners in autocrine promotion of metastasis in esophageal cancer
por: Zhu, Yun, et al.
Publicado: (2021)

Enhancement of mesenchymal stem cells’ chondrogenic potential by type II collagen-based bioscaffolds
por: Piperigkou, Zoi, et al.
Publicado: (2023)

Sirt4: A Multifaceted Enzyme at the Crossroads of Mitochondrial Metabolism and Cancer
por: Tomaselli, Daniela, et al.
Publicado: (2020)

Tumor Treating Fields: At the Crossroads Between Physics and Biology for Cancer Treatment
por: Carrieri, Francesca A., et al.
Publicado: (2020)

Serglycin induces osteoclastogenesis and promotes tumor growth in giant cell tumor of bone
por: He, Yunfei, et al.
Publicado: (2021)

ADAMTS Expression in Colorectal Cancer
por: Filou, Serafula, et al.
Publicado: (2015)

The eEF1A Proteins: At the Crossroads of Oncogenesis, Apoptosis, and Viral Infections
por: Abbas, Wasim, et al.
Publicado: (2015)

Multifaceted WNT Signaling at the Crossroads Between Epithelial-Mesenchymal Transition and Autophagy in Glioblastoma
por: Coelho, Bárbara Paranhos, et al.
Publicado: (2020)

Cold Atmospheric Plasma Attenuates Breast Cancer Cell Growth Through Regulation of Cell Microenvironment Effectors
por: Aggelopoulos, Christos A., et al.
Publicado: (2022)

Serglycin promotes proliferation, migration, and invasion via the JAK/STAT signaling pathway in osteosarcoma
por: Lv, Bin, et al.
Publicado: (2021)

Interplay Between Chemotherapy-Activated Cancer Associated Fibroblasts and Cancer Initiating Cells Expressing CD44v6 Promotes Colon Cancer Resistance
por: Ghatak, Shibnath, et al.
Publicado: (2022)

Chemotherapy induces feedback up-regulation of CD44v6 in colorectal cancer initiating cells through β-catenin/MDR1 signaling to sustain chemoresistance
por: Ghatak, Shibnath, et al.
Publicado: (2022)

Chondroitin sulfate proteoglycan serglycin influences protein cargo loading and functions of tumor-derived exosomes
por: Purushothaman, Anurag, et al.
Publicado: (2017)

XIAP at the crossroads of cell death and inflammation
por: Vucic, Domagoj
Publicado: (2018)

Osteopontin at the Crossroads of Inflammation and Tumor Progression
por: Castello, Luigi Mario, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2e93kr6t9odqlifq1nam0rdng2